Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPO: Extended-release Buprenorphine for Opioid Use Disorder
NCT05164549Phase 3Completed
- Sponsor
- King's College London
- Start
- Aug 2019
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine in opioid use disorder (OUD), sponsored by King's College London. Started Aug 2019; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05164549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05164549.